Allogene Therapeutics Showcases Momentum with Clinical and Platform Advancements in Allogeneic CAR T at AACR 2026
Go back to Allogene Therapeutics Showcases Momentum with Clinical and Platform Advancements in Allogeneic CAR T at AACR 2026| (NASDAQ: ALLO) | Delayed: 1.99 -0.01 (0.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.00 | 52 Week High | $ | |||
| Open | $1.99 | 52 Week Low | $ | |||
| Day High | $1.99 | P/E | N/A | |||
| Day Low | $1.99 | EPS | $ | |||
| Volume | 44,696 | |||||

